Safran SA (LON:0IU8)

London flag London · Delayed Price · Currency is GBP · Price in EUR
290.15
+9.55 (3.40%)
At close: Jul 31, 2025
3.40%
Market Cap101.79B
Revenue (ttm)25.18B
Net Income (ttm)3.70B
Shares Outn/a
EPS (ttm)9.13
PE Ratio27.48
Forward PE30.23
Dividend2.43 (0.88%)
Ex-Dividend DateMay 27, 2025
Volume72,103
Average Volume569,285
Open289.40
Previous Close280.60
Day's Range287.00 - 295.20
52-Week Range184.95 - 295.20
Beta1.16
RSI54.30
Earnings DateJul 31, 2025

About Verve Therapeutics

Safran SA, together with its subsidiaries, engages in the aerospace and defense businesses in France, rest of Europe, the Americas, the Asia-Pacific, Africa, and the Middle East. The company operates through three segments: Aerospace Propulsion; Aircraft Equipment, Defense and Aerosystems; and Aircraft Interiors. The Aerospace Propulsion segment designs, develops, produces, and markets propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, a... [Read more]

Industry Aircraft Engines and Engine Parts
Founded 1896
Employees 96,390
Stock Exchange London Stock Exchange
Ticker Symbol 0IU8
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.